SBH Sciences News
August 2, 2022
MedChem Partners LLC and SBH Sciences have teamed up to offer an integrated solution for drug discovery
April 10, 2020
SBH Offers ELLA Platform for COVID-19 and Cytokine-storm Research
May 02, 2018
Cellaria Forms Collaborative Partnership with SBH Sciences
December 9, 2017
SBH Sciences coauthors "GM604- A multiple-target regulator that provides a novel therapeutic strategy for treatment of ALS and other neurodegenerative diseases"
February 16, 2017
BiomaRx Strikes Collaborative Agreement with SBH Sciences and Woodland Biosciences
June 2, 2016
SBH Sciences and n3D to Start Partnership to Offer 3D Bioprinting for Lead Compound Optimization
May 27, 2016
SOLA Biosciences Makes Cooperative Research and Manufacturing Agreement with SBH Sciences
July 1, 2014
SBH Science Announces the Implementation of Novel Immunoassay Testing Platform
January 27, 2014
Galectin Therapeutics Inc. and SBH Sciences, Inc. Announce the Formation of Galectin Sciences, LLC, a Collaborative Venture to Research and Develop Galectin Inhibitors for Oral Administration
October 25, 2013
SBH Sciences and Reinnervate are offering Alvetex® introductory 3D tumor cell screening services
August 6, 2013
SBH Sciences - News Q3, 2013
July 15, 2013
ZF BIOTOX and SBH Sciences Join forces to offer Cell in Well™ service to the US Biotech Industry
April 4, 2013
Procognia and SBH Sciences Join forces to Offer Services to Biotech Industry
October 10, 2012
Woodland and SBH Sciences Announce New Incubator Model
to support IND-enabling Preclinical Efficacy Studies for Novel Oncology Molecules
August,31, 2012
Galectin Therapeutics Announces Relocation of Corporate Headquarters to Atlanta, GA, while maintaining the excellent work being done by our Collaborators at SBH Sciences.
NEWTON, MA Aug. 31, 2012 Galectin Therapeutics Announces Relocation of Corporate Headquarters to Atlanta, GA while the Boston area location will continue product development and analysis, cell culture models of drug action and the development of analytical tools for complex carbohydrate drugs. The Boston area laboratory effort will be located at SBH Sciences in Natick, MA, where the Company has had a long-term relationship, and will be led by Dr. Eliezer Zomer, the Senior Vice President for Manufacturing and Development.
Read full press release
August,27, 2012
SBH Sciences Celebrates its 15-Year Anniversary
August,22, 2012
A Full Spectrum Of Preclinical Oncology Services is Enabled by the New Strategic Partnership of SBH Sciences and Woodland Oncology Services.
June 19, 2012
Governor Patrick and Israeli Chief Scientist Avi Hasson
Announce First Round of Massachusetts-Israel Innovation Partnership
Grants at Biotechnology Industry Organization (BIO) Convention
Video and Text of the speech given by Raphael Nir, President of SBH Sciences, during the Massachusetts-Israel Innovation Partnership (MIIP) event.
June 14-18, 2012
COVIDIEN, Organix and SBH Sciences are presenting a poster in World Congress of Interventional Oncology (WCIO)
April 30, 2012
SBH Sciences and Cell Assay Innovations
Announce an Agreement to Provide Kinase Cell-based Screening Services
|
